-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JOIwCeHTslf/jz6CWHZwI8ar24Jdv+/kahEc4zdPsQR63BzWfiyshZkUeUGJEsEK ovxYmQB1/vAA78OJP3OcIA== 0001123309-07-000032.txt : 20070430 0001123309-07-000032.hdr.sgml : 20070430 20070223165104 ACCESSION NUMBER: 0001123309-07-000032 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER THERAPEUTICS INC CENTRAL INDEX KEY: 0000876367 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 201499421 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 210 WEST HANSELL ST. CITY: THOMASVILLE STATE: GA ZIP: 31792 BUSINESS PHONE: 229-403-1282 MAIL ADDRESS: STREET 1: 210 WEST HANSELL ST. CITY: THOMASVILLE STATE: GA ZIP: 31792 CORRESP 1 filename1.txt K E N N E T H I. D E N O S, P. C. 10757 SOUTH RIVER FRONT PKWY SUITE 125 SOUTH JORDAN, UTAH 84095 (801) 816-2536 FAX: (801) 816-2599 JTHOMAS@DENOSLAW.COM February 23, 2007 VIA FEDERAL EXPRESS Mr. John L. Krug Mr. Jeffrey Riedler U.S. SECURITIES AND EXCHANGE COMMISSION Division of Corporate Finance 100 F Street, NE, Mail Stop 6010 Washington, D.C. 20549 Telephone (202) 551-3862 Facsimile (202) 772-9217 Re: Cancer Therapeutics, Inc. Registration Statement on Form 10SB File No. 0-52473 Dear Messrs. Krug and Riedler: This firm serves as counsel to Cancer Therapeutics, Inc. in connection with its submission of a registration statement with the Securities and Exchange Commission on Form 10 SB12G. We acknowledge receipt of your comments to our initial filing on February 23, 2007. We thank you for your input and this letter is intended to respond accordingly. Each paragraph number of this letter corresponds to your comments to us dated February 23, 2007, and we have attached two redlined copies and one clean copy, each such copy bound, of our amended registration statement on Form SB-2 for your timely review and comment as appropriate. We note to you that references to page numbers in the registration statement will be with respect to the redlined copies. GENERAL - ------- 1. COMMENT. Pursuant to section 12(g)(1) of the Exchange Act, your registration statement will automatically become effective 60 days after it was filed. If we are not finished with the review by that time, you should withdraw the registration statement and refile it to delay its effectiveness. RESPONSE: Thank for your assistance with the process of arriving at an effective date. SIGNATURES TO FORM 10-SB - ------------------------ 2. COMMENT. The signature block currently refers to Secure Netwerks, Inc. Please revise to indicate the filing is signed on behalf of the registrant, Cancer Therapeutics, Inc. RESPONSE: We have corrected this error on the signature page to reflect the proper name, Cancer Therapeutics, Inc. Please call me with any questions at (801) 816-2536 with any questions. Very truly yours, /s/ John D. Thomas ----------------------- John D. Thomas cc: Robert Oldham, M.D. Michael Low Chene Gardner -----END PRIVACY-ENHANCED MESSAGE-----